Randomized, double-blind, multi-center, phase III clinical trial to evaluate the immunogenicity and safety of MG1109 (egg-based pre-pandemic influenza A/H5N1 vaccine) in healthy adults

• Asıl Yazarlar: Joon Young Song (Yazar), Min Joo Choi (Yazar), Ji Yun Noh (Yazar), Won Suk Choi (Yazar), Hee Jin Cheong (Yazar), Seong-Heon Wie (Yazar), Jin-Soo Lee (Yazar), Gyu-Jin Woo (Yazar), Sang Ho Lee (Yazar), Woo Joo Kim (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2017-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Considering the pandemic potential of avian influenza A/H5N1, development of an effective and well-tolerated vaccine is an essential part of pandemic preparedness plans. This phase III, randomized, double-blind study was conducted to assess the immunogenicity and safety profile of an alum-adjuvanted...